Biohaven Ltd. (BHVN)

PriceLoading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

6 annual periodsNewest to oldest
202520242023202220212020
Research & development$635.1M$795.9M$373.3M$437.1M$181.5M$98.5M
Operating expenses$567.9M$218.9M$114.5M
Operating income−$745.4M−$885.1M−$436.1M−$567.9M−$218.9M−$114.5M
EBITDAderived−$735.5M−$877.3M−$429.1M−$566.5M−$217.5M−$114.4M
Net income−$738.8M−$846.4M−$408.2M−$570.3M−$213.8M−$118.7M
Basic EPSper diluted share-$6.86-$9.28-$5.73-$12.75-$5.43-$3.01
Diluted EPSper diluted share-$6.86-$9.28-$5.73-$12.75-$5.43-$3.01

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys16$42.28M disclosed value
Sells (SEC code S)0$0.00 disclosed value
16 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Nov 17, 2025Form 4Clark George C.VP, Chief Accounting OfficerBuyCommon Shares · indirect17.0K$8.52$144.8K20.0K
Nov 13, 2025Form 4Bailey GregoryDirectorBuyCommon Shares400.0K$7.50$3.00M2.02M
Nov 13, 2025Form 4Coric VladChief Executive OfficerBuyCommon Shares · indirect333.3K$7.50$2.50M740.5K
Nov 13, 2025Form 4Coric VladChief Executive OfficerBuyCommon Shares · indirect333.3K$7.50$2.50M1.20M
Nov 13, 2025Form 4CHILDS JOHN WDirectorBuyCommon Shares · indirect3.33M$7.50$25.00M5.65M